摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-methylimidazo[1,2-a]quinoxalin-4(5H)-one | 133307-46-7

中文名称
——
中文别名
——
英文名称
2-methylimidazo[1,2-a]quinoxalin-4(5H)-one
英文别名
2-methyl-5H-imidazo[1,2-a]quinoxalin-4-one
2-methylimidazo[1,2-a]quinoxalin-4(5H)-one化学式
CAS
133307-46-7
化学式
C11H9N3O
mdl
——
分子量
199.212
InChiKey
SISRFMJKDBQDEO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    46.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    4-methyl-1-(2-nitrophenyl)-1H-imidazole 在 palladium on activated charcoal 氢气 作用下, 以 乙醇 为溶剂, 25.0 ℃ 、344.73 kPa 条件下, 反应 3.5h, 生成 2-methylimidazo[1,2-a]quinoxalin-4(5H)-one
    参考文献:
    名称:
    Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs
    摘要:
    A series of novel imidazoquinoxalinones and their aza analogues were prepared by the cyclization of o-amino(H-1-imidazol-1-yl)aryls and heteroaryls with carbonyldiimidazole. The compounds were screened for inhibition of Type I and Type IV phosphodiesterases (PDE's) and evaluated for their vasorelaxant and positive inotropic activities in vitro. In general, compounds having potent PDE inhibitory activity also possessed good inotropic and vasodilator activity, although linear correlations between these activities could not be established.
    DOI:
    10.1021/jm00113a002
点击查看最新优质反应信息

文献信息

  • Imidazoquinoxalinones, their aza analogs and process for their preparation
    申请人:BERLEX LABORATORIES, INC.
    公开号:EP0400583A1
    公开(公告)日:1990-12-05
    This invention relates to novel imidazoquinoxalinones and their aza analogs and to a process for their preparation. The compounds of this invention have been found to have inodilatory, vasodilatory, venodilatory and other pharmacologic effects.
    本发明涉及新型咪唑喹喔啉酮及其氮杂类似物,以及其制备工艺。已发现本发明的化合物具有扩张血管、扩张静脉和其他药理作用。
  • US5055465A
    申请人:——
    公开号:US5055465A
    公开(公告)日:1991-10-08
  • Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs
    作者:David D. Davey、P. W. Erhardt、E. H. Cantor、S. S. Greenberg、W. R. Ingebretsen、J. Wiggins
    DOI:10.1021/jm00113a002
    日期:1991.9
    A series of novel imidazoquinoxalinones and their aza analogues were prepared by the cyclization of o-amino(H-1-imidazol-1-yl)aryls and heteroaryls with carbonyldiimidazole. The compounds were screened for inhibition of Type I and Type IV phosphodiesterases (PDE's) and evaluated for their vasorelaxant and positive inotropic activities in vitro. In general, compounds having potent PDE inhibitory activity also possessed good inotropic and vasodilator activity, although linear correlations between these activities could not be established.
查看更多